Secondary cutaneous mucormycosis post-COVID-19: Case series from a tertiary center
Background: Mucormycosis is an angioinvasive mucorales fungal infection. Cutaneous type formed 10.5% of cases in India in precovid-19 era. Glucocorticoid-induced immunosuppression and hyperglycemia, reusable oxygen humidifiers in COVID-19 therapy, and preexisting uncontrolled diabetes mellitus contr...
Saved in:
Main Authors: | B Abhirami (Author), Prabhat Kumar (Author), Dharmendra Kumar Mishra (Author), Satyendra Prasad Yadav (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microneedling and 5-Fluorouracil in Treating Stable Vitiligo in Hitherto Unstudied High Prevalence Population
by: B Abhirami, et al.
Published: (2024) -
Cutaneous mucormycosis
by: Ana Daniela Castrejón-Pérez, et al.
Published: (2017) -
Post-COVID, neurosurgical interventions in rhinocerebral mucormycosis, an institutional experience
by: Samrendra Kumar Singh, et al.
Published: (2022) -
Atypical clinical features of post COVID‐19 mucormycosis: A case series
by: Hassanien A. Al‐jumaily, et al.
Published: (2023) -
Post COVID-19 mucormycosis in critical care settings: A prospective cohort study in a tertiary care center in Egypt
by: Nahawand A. EL-Deeb, et al.
Published: (2024)